CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −272 | $137.30 | $37K | 7,507 |
| 2024-04-01 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −272 | $79.02 | $21K | 5,172 |
| 2024-03-21 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +5,000 | $103.52 | $518K | 12,507 |
| 2024-03-21 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −5,000 | $145.06 | $725K | 7,507 |
| 2024-03-21 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −5,000 | $103.52 | $518K | 27,049 |
| 2024-03-14 | BENEVICH ERIC Chief Commercial Officer | Option exercise 10b5-1 | +5,479 | $79.02 | $433K | 46,257 |
| 2024-03-14 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −5,479 | $139.38 | $764K | 40,778 |
| 2024-03-14 | BENEVICH ERIC Chief Commercial Officer | Option exercise 10b5-1 | +69,521 | $81.05 | $5.6M | 110,299 |
| 2024-03-14 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −69,521 | $139.38 | $9.7M | 40,778 |
| 2024-03-14 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −5,479 | $79.02 | $433K | 33,881 |
| 2024-03-14 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −69,521 | $81.05 | $5.6M | 12,587 |
| 2024-03-14 | MORROW GEORGE J Director | Option exercise 10b5-1 | +20,000 | $39.79 | $796K | 20,000 |
| 2024-03-14 | MORROW GEORGE J Director | Sale 10b5-1 | −20,000 | $139.42 | $2.8M | 0 |
| 2024-03-14 | MORROW GEORGE J Director | Option exercise 10b5-1 | +20,000 | $39.79 | $796K | 20,000 |
| 2024-03-14 | MORROW GEORGE J Director | Sale 10b5-1 | −20,000 | $139.41 | $2.8M | 0 |
| 2024-03-14 | MORROW GEORGE J Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −20,000 | $39.79 | $796K | 20,000 |
| 2024-03-14 | MORROW GEORGE J Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −20,000 | $39.79 | $796K | 0 |
| 2024-03-13 | POPS RICHARD F Director | Option exercise 10b5-1 | +23,200 | $42.76 | $992K | 52,712 |
| 2024-03-13 | POPS RICHARD F Director | Sale 10b5-1 | −23,200 | $140.33 | $3.3M | 29,512 |
| 2024-03-13 | POPS RICHARD F Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −23,200 | $42.76 | $992K | 0 |
Page 34 of 49 · 963 trades